Skip to main content

Table 2 Summary results of bivariate model analysis and sub-group analysis

From: FDG-PET/CT versus bone marrow biopsy in bone marrow involvement in newly diagnosed paediatric lymphoma: a systematic review and meta-analysis

Summary results of bivariate model analysis

Bivariate Model Analysis

 Sen (95% CI)

Spe (95% CI)

PLR (95% CI)

NLR (95% CI)

DOR (95% CI)

AUC (95% CI)

PET/CT

 0.97(0.93-0.99)

0.99(0.98-0.99)

79.9(42.7-149.6)

0.03(0.01-0.17)

2414.6(989.6-5891.4)

1.00(0.99-1.00)

BMB

 0.44(0.34-0.55)

1.00(0.92-1.00)

1277.1(4.8-337317.5)

0.56(0.46-0.68)

2274(9-596153)

0.71(0.67-0.75)

Subgroup Analyses

Subgroup

Sen (95% CI)

Spe (95% CI)

PLR (95% CI)

NLR (95% CI)

DOR (95% CI)

AUC (95% CI)

PET/CT

 HL

0.97(0.93-0.99)

0.99(0.97-0.99)

66.4(36.7-120.3)

0.03(0.01-0.07)

2532(865-7412)

1.00(0.99-1.00)

 NHL

0.94(0.85-0.97)

0.99(0.94-1.00)

68.9(15.7-302.9)

0.06(0.03-0.16)

1062(193-5853)

0.99(0.98-1.00)

BMB

 HL

0.32(0.18-0.50)

1.00(0.91-1.00)

231.8(2.9-18534.3)

0.68(0.53-0.87)

341(4-30241)

0.65(0.61-0.69)

 NHL

0.55(0.45-0.64)

0.99(0.95-1.00)

77.1(10.8-547.6)

0.46(0.37-0.56)

169(23-1250)

0.98(0.96-0.99)